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ABSTRACT OF THE DISSERTATION
Executive Dysfunction is Predictive of Clinical Symptomatology in
22q11.2 Deletion Syndrome
by
Chinonyere Kemdirim Bello
Doctor of Philosophy, Graduate Program in Clinical Psychology
Loma Linda University, December 2015
Dr. Carrie Bearden, Dr. Richard Hartman, Chairpersons

By adulthood, 25%- 30% of individuals with 22q11.2 deletion syndrome (22qDS)
develop a psychotic disorder, often schizophrenia, and it is not understood why. Given
the known genetic etiology of this disorder and the greatly elevated risk for development
of schizophrenia, this group offers the possibility of defining a seemingly homogenous
maturational pathway to psychosis. Neurocognitive deficits have been increasingly
recognized as an important dimension of schizophrenia, particularly in the executive
domain. Thus, we assessed multiple aspects of executive cognition in 22qDS, in order to:
1) characterize performance across this domain as compared to age-matched healthy
controls; and 2) determine whether executive function performance is significantly
predictive of positive and negative psychotic symptoms in 22qDS above and beyond nonverbal functioning. We assessed psychomotor speed and mental flexibility (Trails-B),
working memory (Letter-Number Sequencing: LNS) and D-KEFS verbal fluency.
Psychotic symptomatology was measured using scores obtained from the Structured
Interview for Prodromal Syndromes (SIPS). 22qDS patients (N= 48, mean age: 15.23)
showed impairment relative to healthy controls (N= 37, mean age: 14.97) on all measures
of executive functioning. Regression analysis revealed that executive deficits are

xi

predictive of positive psychological symptomatology above and beyond non-verbal
deficits. Specifically, D-KEFS verbal fluency added meaningfully to the prediction of
positive psychiatric symptoms. Given this significant prediction it is suggested that
executive function may be an important domain for providing information about the
development of psychosis.
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CHAPTER ONE
INTRODUCTION

Schizophrenia
Schizophrenia is a debilitating disorder that places a burden on the individual,
family unit, and society (Harrison, & Weinberger, 2005). The cost to the individual
involves personal suffering, while the detriment to the family unit involves the burden of
care giving. Society is disrupted by the individual’s hospitalizations, need for long-term
care, and loss of productivity (Davis & Drummond, 1994; Guest & Cookson, 1999). A
review by Knapp et al. (2004) examined the cost-of-illness estimate internationally. They
suggested that the expense includes national total, direct, and indirect costs; direct,
indirect, and total costs per patient each year; inpatient services, medication, lost
productivity, mortality, family impact, and criminal justice system costs. Given the
expenditure involved with schizophrenia, it is widely studied specifically for its genetic
basis. However, despite intensive search for the schizophrenia susceptibility gene, the
genetic basis of this disorder remains elusive (Baron, 2001).
22q11.2 deletion syndrome (22qDS) may provide a means of advancing our
understanding of the pathophysiology underlying the development of schizophrenia. By
adulthood, approximately 25% to 30% of individuals with 22qDS develop a psychotic
disorder, often schizophrenia (Bassett & Chow 1999; Murphy 2002; Murphy, Jones, &
Owen, 1999; Murphy & Owen, 1996) and it is not understood why. Due to the high
frequency of schizophrenia in 22qDS patients, the 22q11.2 region is now thought to be
one of the main schizophrenia susceptibility loci in humans (Bassett and Chow 2008;
Insel 2010). Cognitive deficits, particularly executive dysfunction are core features of
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schizophrenia. These deficits are relatively stable across clinical state changes and are
present before the onset of clinical/psychotic symptoms (Levin et al. 1989; Crawford et
al. 1993; Evans et al. 1997). Executive deficits are also prominent in 22qDS. Therefore
given these relationships, we evaluated whether executive deficits are associated with
clinical symptomatology.

22q11.2 deletion syndrome
22q11.2 deletion syndrome, velo-cardio-facial syndrome (VCFS), DiGeorge
syndrome, and Shprintzen syndrome are all different names for a chromosomal deletion
of one segment of the chromosome pair at band q11.2. These syndromes were all
originally thought to be different genetic conditions but it is now known that they all refer
to individuals who have a 1.5 to 3 megabase (unit of length for DNA fragments)
microdeletion on the long (q) arm of chromosome 22 (Shprintzen, 2008) (See Appendix
A). The 1.5 to 3 megabase microdeletion covers a region containing 35 to 60 genes
(Drew et al., 2011; Edelmann et al., 1999). The deletion can be detected by a diagnostic
procedure called Fluorescence In Situ Hybridization (FISH). This procedure is used to
detect and localize the presence or absence of specific DNA sequences on chromosomes
FISH uses fluorescent probes that bind to the missing segment of DNA on one
chromosome if it is missing (Amann & Fuchs, 2008). With this procedure, 22q11.2DS is
now often detected in infancy via genetic testing.
We will refer to this condition as 22qDS. 22qDS is one of the most common
multiple anomaly syndromes in human beings. Its prevalence is estimated at 1/4000 live
births (Basset et al, 1998). Up to 93% of cases occur de novo, whereas 7% of deletions
are inherited from a parent (Phillip and Basset, 2011). 22qDS is characterized by
2

multiple developmental anomalies; over 180 have been identified (Shprintzen, 2000).
These include cleft palate and velopharyngeal insufficiency which is a condition
characterized by hypernasal speech, nasal emission and turbulence, and in some cases
nasal regurgitation of fluids (Saunders, Hartley, Sell & Somerlad, 2004). Furthermore,
the anomalies include hypernasality, cardiac defects, endrocrinological and neurological
problems (Robin & Shprintzen, 2005). Craniofacial anomalies (cleft-palate, velopharyngeal insufficiency) occur in 69-100% of children born with this syndrome.
Thymic and parathyroid defects including hypocalcemia (low serum calcium blood
levels) occur in 17-60% of children born with this condition. Cardiovascular problems
occur in 70% of children with 22qDS, as the first presenting symptom is usually a
congenital heart defect (Robin and Shprintzen, 2005; Kobrynski and Sullivan, 2007).
The multiple anomalies of 22qDS are associated with behavioral, psychiatric, and
cognitive phenotypes.
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CHAPTER TWO
22Q11.2 DELETION SYNDROME

Behavioral Phenotype of 22qDS
The behavioral phenotype of 22qDS was first described by Golding- Kushner et
al. (1985). They suggested that there is a distinctive temperament that severely hinders
successful social contact. Golding-Kushner and colleagues explained a profile of
withdrawn, socially isolated individuals that displayed “extremes of behavior” including
disinhibition, impulsiveness, and shyness. Papolos, Faedda, Veit, Goldberg, Morrow
and Kucherlapati (1996) described a profile comparable to Golding-Kushner of 22qDS
during childhood as they suggested this phenotype to include disinhibition, inattention,
impulsivity, anxiety, schizoid features, social withdrawal, and flat affect. Similarly,
Antshel et al. (2007) found that children with 22qDS were rated by their parents as being:
less regular in their daily habits; less able to focus/sustain attention; less
cheerful/pleasant; less likely to stay with an activity for a long time; and less able to
respond flexibly to changes in the environment. Aneja et al., (2007) found that manic
symptoms in 22qDS predicted significantly elevated scores on four Child Behavior
Checklist (CBCL) subscales, namely anxiety, somatization, thought, and conduct
problems. There are other behavioral features indicated in 22qDS, but they are not well
captured by standard assessment scales. These include difficulties socializing,
dependency on a caregiver, impulsivity, temper outbursts, perseverative speech and
repetitive behaviors (Bassett et al., 2003; Swillen et al., 2000). There is also an
associated psychiatric phenotype with this syndrome, as described below.
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Psychiatric Phenotype of 22qDS
There are several psychiatric disorders related to 22qDS, with Attention deficit
hyperactivity disorder (ADHD) being the most prevalent. ADHD occurs in
approximately one-third to half of all children with 22qDS (Gothelf, Presburger, Namani
et al., 2004; Antshel et al., 2006; Zagursky et al., 2006). High rates of affective disorders,
anxiety disorders, phobic disorders, and obsessive- compulsive disorders in children and
adults with 22qDS have been reported as well (Murphy, Jones, and Owen, 1999;
Feinstein et al., 2002; Gothelf et al., 2004; Antshel et al., 2006). Several studies have
assessed and characterized psychiatric features in this population.
In particular, using structured diagnostic interviews Papalos et al., 1996 found that
64% (N = 16 of 25) of patients met DSM-III-R criteria for a spectrum of bipolar disorders
with full syndromal onset in late childhood or early adolescence (mean age at onset = 12
years, SD = 3). In addition, 20% (N = 5) met DSM-III-R criteria for attention deficit
hyperactivity disorder (ADHD), and 16% (N = 4) met criteria for attention deficit
disorder without hyperactivity. Similarly, using the Children's Interview for Psychiatric
Symptoms, Child (ChIPS) and Parent (P-ChIPS) Forms (Weller et al., 2000), Jolin et al.,
1998) found that participants had a mean of two DSM-IV psychiatric disorders. 79% of
these participants met criteria for at least one DSM-IV psychiatric disorder and over one
third had three or more diagnoses. 12.5% met criteria for major depression, 54% for
anxiety disorders, 38% for attention-deficit/hyperactivity disorder, and 38% for
oppositional defiant disorder. Notably, in adulthood many of these children develop
psychoses, specifically schizophrenia.
By adulthood, estimates of approximately 25%- 30% have been reported of
individuals with 22qDS developing a severe psychiatric disorder, often schizophrenia
5

(Bassett & Chow 1999; Murphy 2002; Murphy, Jones, & Owen, 1999; Murphy & Owen,
1996) and it is not understood why. However, due to the high frequency of schizophrenia
in 22qDS patients, the 22q11.2 region is now thought to be one of the main schizophrenia
susceptibility loci in humans (Bassett and Chow 2008; Insel 2010). Conversely, about
1% of individuals with schizophrenia in the general population have 22q11.2 deletions
(Bassett et al. 2010).
In a sample of 100 patients with 22qDS Shprintzen et al. (1997) and Chow et al.
(1999) found that by adulthood, 10-30% met criteria for chronic paranoid schizophrenia.
This finding was congruent with what Shprintzen and colleagues discovered in 1992.
They reported psychotic symptoms, which they described as resembling ‘‘chronic
paranoid schizophrenia’’ in 12 of 90 children and adults with 22qDS (Shprintzen et al.,
1992). Participants with 22qDS, an age and IQ matched control group, and the
parents/caregivers for participants under age 16 completed a semi-structured interview.
The Child and Adolescent Psychiatric Assessment (CAPA; Angold et al, 1995) was used
to obtain a descriptive record of each participant’s current and previous (3 months)
mental-state. Psychiatric disorders were more prevalent among those with the syndrome
and included attention deficit, depression, and anxiety symptoms. Additionally, nearly
half of the participants with 22qDS reported transient psychotic experiences (Baker and
Skuse, 2005).
Gothelf and colleagues conducted baseline psychiatric, psychological, and
adaptive functioning evaluations of children with 22qDS and comparison subjects with
idiopathic developmental disability matched for age and IQ. Five years later the
participants were evaluated again. Although the two groups had similar baseline
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neuropsychiatric profiles, at follow up 32% of the 22qDS group met DSM-IV criteria for
psychotic depression, schizoaffective disorder, schizophrenia or schizophreniform
disorder (Gothelf et al., 2007). Furthermore, Murphy et al. (1999) evaluated adults with
22qDS using either the Schedules for Clinical Assessment in Neuropsychiatry or
Psychiatric Assessment Schedule for Adults With Developmental Disability if their IQ
was lower than 50. Results revealed that 30% of the adults with 22qDS had a psychotic
disorder, and 24% met DSM-IV criteria for schizophrenia. In addition to high rates of
psychopathology and particularly psychosis, a characteristic cognitive profile has also
been observed. However, the specific cognitive risk factors for the development of
psychosis have not yet been identified.

Cognitive Phenotype of 22qDS
22qDS is associated with general cognitive functioning in the low borderline
range to mentally retarded range (Antshel et al, 2008; Eliez et al., 2000). De Smedt,
Devriendt, Fryns, Vogels, Gewillig, and Swillen (2007) found that 60% of the children
showed borderline to normal intelligence (FSIQ > 70), whereas an intellectual disability
(FSIQ < 70) was noted in 40% of the children. The 22qDS cognitive profile includes
impairment in speech and language. Speech onset is mildly delayed and receptive
language tends to develop more rapidly than expressive language. These children often
have a hypernasal speech pattern (75%) and articulation impairment (Golding-Kushner,
2000).
Neuropsychological testing in this population suggests a relative strength in
verbal abilities relative to non-verbal abilities (Bearden, Woodin, Wang, Moss,
McDonald-McGinn, Zackai, Emanuel, & Cannon, 2001; Wang et al., 1998). In early
7

childhood, many individuals with the syndrome present with a cognitive profile that is
similar to that profile identified in children with non-verbal learning disabilities (NVLD),
i.e., performance IQ significantly lower than verbal IQ (Goldberg et al., 1992; De Smedt
et al., 2009; Jacobson et al., 2010; Swillen et al., 1999; Moss et al., 1999; Swillen et al,
2000). Goldberg, Motzkin, Marion, Scambler, and Shprintzen (1992) suggests that this
discrepancy is related to a combination of impairments in visuospatial ability, planning
ability, non-verbal reasoning, and deficits in novel reasoning and concept formation.
Henry, Van Amelsvoort, Morris, Owen, Murphy, and Murphy (2002) found that
in comparison to demographically matched controls, 22qDS participants demonstrated
significant impairments in visuoperceptual ability, problem solving and planning, and
abstract and social thinking. These demonstrated deficits are similar to the ones
suggested by Goldberg and colleagues (1992).
Bearden et al. (2001) assessed 22qDS children with a comprehensive
neuropsychological battery to evaluate the nonverbal learning deficit that has been
previously identified in this population. A significant discrepancy was found between
visual-spatial and verbal abilities within the domain of memory. This was taken to
suggest that a differential impairment in visual-spatial information-processing exists,
consistent with the previously found non-verbal deficits. Swillen et al. (1999) also found
a Verbal IQ-Performance IQ discrepancy, in favor of VIQ, with significantly better
scores for reading (decoding) and spelling. Weaknesses were seen in arithmetic, tactileperceptual skills, visual-perceptual abilities, visual-spatial skills, (extremely poor)
psychomotor skills, processing of new and complex material, and visual attention. Eliez
et al. (2001) conducted a fMRI study of math reasoning in eight children with 22qDS.
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Their results indicate that children with 22qDS showed less activation than controls in the
angular gyrus, a posterior parietal brain region typically activated during such tasks. In
addition, increased activation was observed in the left supramarginal gyrus as a function
of task difficulty. Eliez et al. (2001) concluded that children with 22qDS may utilize an
atypical and less effective circuit for completing math problems, which may lead to
impairment. Furthermore, visual attention impairment was also noted in a study by Sobin
et al. (2005). Deficits in executive function and planning are also a prominent part of the
22qDS cognitive phenotype.
Goldman-Rakic has defined executive function as a set of various interrelated
cognitive abilities that operate metaphorically as a company ‘‘executive’’ and are thought
to be largely mediated by prefrontal-parietal and prefrontal-subcortical circuits
(Goldman-Rakic, 1995). Executive function includes planning, cognitive flexibility,
abstract thinking, rule acquisition, initiating appropriate actions and inhibiting
inappropriate actions, and selecting relevant sensory information (Stuss and Knight,
2002). The executive functions that are most often evaluated in the 22qDS literature are
cognitive flexibility, response inhibition, and working memory both verbal and
nonverbal. Previous research has demonstrated an executive deficit in 22qDS
behaviorally, anatomically, and in the performance of neuropsychological tasks.
In a study by Kiley-Brabeck and Sobin parents rated their child with 22qDS and
the unaffected sibling with the Social Skills Rating System (SSRS) and Behavior
Inventory of Executive Function (BRIEF). Children with 22qDS had significantly lower
SSRS ratings for cooperation, assertion, responsibility, and self-control. On the BRIEF
the 22qDS children had significantly higher ratings for initiation, planning, working
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memory, and monitoring. These results indicate that the children with 22qDS display
poor executive functioning in that they have lower initiation, planning, working memory,
and monitoring skills as compared to their unaffected siblings (Kiley- Brabeck and Sobin,
2006).
Sobin and colleagues also demonstrated a deficit in executive function in 22qDS
as compared to their unaffected sibling. Participants were administered a developmental
neuropsychological assessment (NEPSY) and the Stanford–Binet Intelligence Scale.
Although, no differences were found between the groups on tests of verbal or quantitative
ability, children with 22qDS had impaired performance in the executive domain (Sobin et
al., 2005). An earlier study by Sobin et al. 2004 suggested an executive attention deficit
in 22qDS as compared to unaffected siblings. Performances on specific tasks have been
indicative of executive dysfunction in 22qDS.
Woodin et al. (2001) used the Trail-making Test to examine cognitive function in
22qDS. Their results suggested that children and adolescents with 22qDS struggle more
on the Trail-making test Part B, a test of cognitive flexibility and set-shifting. This result
was suggestive of poorly developed working memory (Woodin et al., 2000). LajinessO’Neill and colleagues examined the cognitive profile of children with 22qDS. Visualspatial working memory was found to be less well developed than simple object memory
(Lajiness- O’Neill et al., 2005). On the Wisconsin Card Sorting Test, Lewandowski et al.
(2007) reported that children with 22qDS made more perseverative errors than control
participants. Working memory deficits were demonstrated in a 22qDS group as
compared to controls on a serial order task (Majerus et al., 2007). Furthermore, Wang et
al. (2000) assessed verbal working memory using a digit span task. Children with 22qDS
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performed less well than control participants. Anatomical studies have also indicated an
executive deficit involved in 22qDS.
In 2007, Kates and colleagues used functional magnetic resonance imaging
(fMRI) to examine neural activation during non-spatial working memory tasks in
children with 22qDS, their unaffected siblings, and controls with the same proportion of
learning disabilities as the 22qDS participants. Intelligence and academic achievement
were assessed with the Wechsler Intelligence Scale for Children, 3rd Edition and the
Wechsler Individual Achievement Test, 2nd edition (WIAT-II). A two–back, non-spatial
working memory task was administered while the participants were in the scanner. The
task required participants to respond using a button box when they saw the same letter as
two letters back for the experimental condition and during the control block, participants
were asked to respond only to the letter “X”. Results revealed that during the
experimental condition (relative to the control condition) individuals with 22qDS
exhibited significant activation in the left and right inferior frontal gyri and the left and
right inferior parietal lobule. However, in analyses where subjects were matched for
performance, relative to performance-matched youth with 22qDS, both the control and
the sibling samples recruited significantly more voxels in the frontal cortex, including the
cingulate, the precentral gyrus, and the operculum. These findings suggest that frontal
lobe function is disrupted in youth with 22qDS (Kates et al., 2007).
Another study by Kates and colleagues examined the morphology of the frontal
lobe and the caudate nucleus in children with 22qDS. Volumes of the caudate nucleus
and frontal lobe were compared between 10 children with 22qDS and 10 matched
controls. Frontal deep white matter was reduced significantly (by about 23%) in
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participants with 22qDS relative to controls. Frontal and prefrontal volumes were also
reduced as compared to controls. These findings suggest frontostriatal dysfunction in
children with 22qDS (Kates et al. 2004). Cognitive impairment is also seen in
psychoses/schizophrenia, with executive dysfunction being a prominent feature.
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CHAPTER THREE
PSYCHOSES/SCHIZOPHRENIA AND NEUROCOGNITION

Research studies
Neurocognitive deficits have been increasingly recognized as an important
dimension of schizophrenia (Bilder et al., 2000; Green et al., 2000). Wide ranges of
cognitive impairments have been reported in people with schizophrenia, particularly
problems in attention, verbal and working memory, and executive function (Rushe et al.,
1999; Morris et al., 1995; Kravariti et al., 2003).
Kravariti and colleagues investigated cognitive function in adolescents with
recent onset schizophrenia as compared to healthy controls. A comprehensive battery
was used including measures of intelligence, memory, and executive function paradigms.
Specifically, the executive paradigms evaluated were planning and problem solving,
spatial working memory, sequencing and mental flexibility, and dual-task performance.
Significant deficits were seen in the schizophrenia participants as compared to the
controls. Deficits were seen in full scale IQ, performance IQ, verbal memory, visual
memory, general memory, delayed recall, perceptual-motor processing time, betweensearch errors/spatial working memory, and spatial strategy.
Problem solving ability was examined in participants with schizophrenia (DSMIII-R diagnosis) as compared to controls. The 3-D computerized Tower of London task
was used. Participants with schizophrenia showed impairments in motor initiation and
execution. They were also impaired on accuracy of problem solving which includes
number of moves above the minimum and number of problems solved using the
minimum number of moves. Results indicated that the schizophrenia group demonstrated
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a pattern of performance that is similar to performances by participants with frontal lobe
lesions (Morris, Rushe, Woodruffe, and Murray, 1995).
Holmen and colleagues examined whether a battery of tests, the Measurement and
Treatment Research to Improve Cognition in Schizophrenia (MATRICS), would be
useful in detecting differences between a schizophrenia group and healthy controls.
Speed of processing, attention/vigilance, working memory, verbal learning, visual
learning, reasoning and problem solving, social cognition, and intelligence were assessed.
There were significant differences in the performances between the schizophrenia group
and the controls on every domain except for social cognition. There was a generalized
neurocognitive deficit of 0.8–1.8 SD’s compared with controls, with verbal learning,
working memory, and visual learning being the most affected areas (Holmen et al.,
2010).
Bressi et al. (1996) evaluated the hypothesis that patients with schizophrenia have
an impaired central executive component of working memory. Participants with
schizophrenia (DSM-IV criteria) and age-education matched controls were asked to
combine the performance on a computerized tracking task with articulatory suppression,
simple reaction time (RT) to a tone, or auditory digit span concurrently. The
schizophrenia group’s performance deteriorated when tracking was combined with
reaction time. The authors concluded that these results are reflective of a dysfunction of
central executive working memory in schizophrenia (Bressi et al., 1996).
Bilder and colleagues aimed to provide a comprehensive neuropsychological
characterization of participants with schizophrenia after the first episode of illness as
compared to healthy controls. Participants met diagnostic criteria for paranoid,

14

disorganized, catatonic, and undifferentiated schizophrenia or schizoaffective disorder.
Neuropsychological testing was conducted to assess the language, memory, attention,
executive, motor, and visuospatial domains. Results revealed that the schizophrenia
group was more impaired than the comparison group on every neuropsychological
dimension measured. The overall profile mean for the patients was –1.53, indicating a
generalized deficit of approximately 1.5 standard deviations. The schizophrenia group
showed greater impairment on certain domains. Specifically, this group demonstrated
significantly more impairment on memory and executive areas (Bilder et al., 2000).
Toulopoulou, Morris, Rabe-Hesketh, and Murray (2003) evaluated memory and
executive processing in a group of schizophrenic patients, their healthy relatives, and
normal controls. Verbal and visual memory was assessed as well as various aspects of
executive function (problem solving, planning ability, spatial working memory, working
memory, strategy formation, mental flexibility). Neuropsychological function in the
patients was lower than that of their relatives, which in turn was lower than that of
controls on most measures. Verbal memory/learning and visual memory/learning were
impaired as well as aspects of executive function including planning and spatial working
memory (Toulopoulou et al., 2003).

Deficits in cognition
Cognitive impairment is considered a core feature of schizophrenia that includes
problems in speed of processing, attention/vigilance, verbal learning, visual learning,
social cognition and executive aspects including working memory, cognitive flexibility,
planning, and reasoning and problem solving (Green 2006, Goldman-Rakic 1986;
Goldberg et al. 1990; Morris et al. 1995). As a core feature, these cognitive deficits are
15

not attributed to the symptoms of schizophrenia or of the treatment of the illness with
antipsychotic medication. Instead, cognitive deficits are relatively stable across clinical
state changes, present before the onset of clinical/psychotic symptoms, and may be seen
in attenuated form in unaffected first-degree relatives of people with schizophrenia
(Finklestein et al., 1997; Gold 2004; Crow, Done, and Sacker, 1995). Given this, it is
important to assess cognitive function in 22qDS, considering its relationship with
schizophrenia. Deficits in cognition, specifically executive deficits given their
consistency and prominence in schizophrenia, may be associated with conversion to this
disorder in 22qDS. Therefore, assessing whether these deficits are associated with
psychological symptoms in 22qDS is valuable.
It is important to understand the predictors of schizophrenia in 22qDS given that
schizophrenia is considered to be the most expensive and difficult psychiatric disorder to
treat (Capri 1994; Torrey 2002; Knapp 1997). One of the factors that greatly contributes
to the cost and difficulty in treating the illness is functional impairment (Kenny and
Meltzer, 1991). In 1996 Green suggested that these core cognitive deficits are an
enduring feature of the illness and that these deficits are more important than positive and
negative symptoms in predicting functional outcome.
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CHAPTER FOUR
MATERIALS AND METHODS

Objective
Given that people with 22qDS have high rates of psychosis in adulthood and it is
not understood why, we are attempting to identify factors that might be associated with
who is likely to develop psychosis. Executive functioning is a prominent feature in
schizophrenia, thus we believe that executive deficits will be associated with psychotic
symptoms. In fact in a study of four patients with 22qDS who developed schizophrenia,
they were retrospectively discovered to have displayed delayed motor development,
language deficits, learning disabilities, mental retardation, early age of onset, chronic and
disabling course of illness and poor response to classical neuroleptic drugs and
electroconvulsive therapy before adulthood (Gothelf et al., 1999). Premorbid assessment
may have been able to identify these differences. Thus, we intend to evaluate child to
early adulthood participants with 22qDS in terms of executive functioning to characterize
performance across this domain as compared to age-matched healthy controls and to
determine if executive deficits are associated with psychotic symptoms. Given that
psychoses do not fully manifest until adulthood, efforts to recognize the more mild,
subthreshold psychotic symptoms that occur in 30–50% of youth with 22qDS (Feinstein
et al., 2002; Baker & Skuse, 2005), will be valuable. Increased methods to identify these
premorbid symptoms are needed. It is possible that 22qDS patients who eventually
develop psychosis exhibited subthreshold psychotic symptoms early on that differentiated
them from those that did not go on to develop a psychotic disorder (Gothelf et al., 2004).
We will examine if these subthreshold symptoms can be indicated by executive
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dysfunction. Using executive deficits as an indication of psychopathology in 22qDS
participants is novel.
Although non-verbal learning deficits are characteristic in 22qDS, we speculate
that executive function deficits will provide greater association with psychotic symptoms.
Therefore, we will examine if executive deficits are associated with psychopathology
above and beyond non-verbal deficits. We will evaluate the following hypotheses:

Hypotheses
1. 22qDS patients will show the greatest impairment relative to healthy controls on
measures of psychomotor speed and mental flexibility (Trail-making test part B),
working memory (Letter-Number Sequencing), and the D-KEFS verbal fluency
composite.
2.

Executive deficits in working memory (Letter-Number Sequencing), and the DKEFS verbal fluency composite will be significantly predictive of total positive
and total negative symptomatology above and beyond non-verbal visuospatial
deficits (copy portion of the Rey Osterrieth Complex Figure Test) in 22qDS
patients.

Study Design
A cross-sectional design was used for this project. This project focused upon the
Trail-making Test Part B, University of Maryland Letter-Number Span, and DKEFS
Verbal Fluency as measures of executive function. To examine non-verbal function, the
Rey Osterrieth Complex Figure Test was evaluated (ROCFT). The Structured Interview
for Prodromal Syndromes (SIPS) was used to measure psychiatric symptoms. Psychotic
18

symptom severity is defined as a quantitative trait, according to SIPS criteria (i.e., ratings
range from 0 [not present] to 6 [‘severe and psychotic’]). Dimensional ratings of 3 or
higher on SIPS positive symptoms (“prodromal” or sub-psychotic range) are associated
with high rates of subsequent conversion to overt psychosis and are also associated with
substantial functional impairment. Total positive and total negative symptoms were
obtained by adding together the ratings of individual questions.

Trail-making Test Part B
The Trail Making Test (Reitan and Wolfson, 1985) is a measure of attention,
speed, and mental flexibility. It requires the participant to connect encircled numbers
randomly arranged on a page in proper order and then encircled numbers and letters in
alternating order. Test re-test reliability in young adults retested after an interval of three
weeks on the TMT B was .75 (Bornstein et al., 1987). Inter-rater reliability for the TMT
has been reported as .94 for part A and .90 for part B (Fals-Stewart, 1991). The validity
of the TMT shows that Parts A and B correlate moderately well with each other (r= .31 to
.60) suggesting that they measure similar although somewhat different functions
(Heilbronner et al., 1991; Pineda and Merchan, 2003; Royan et al., 2004). Royan et al.
(2004) reported that the TMT-B correlated moderately well with scores on other
measures of speeded processing (i.e., Symbol Digit Modality Test and a variant of the
PASAT).

University of Maryland Letter-Number Span
The University of Maryland Letter-Number Span task is a measure of verbal
working memory. This task requires mental reordering of orally presented lists with
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letters and numbers and repeating them back (Holmen at al., 2010).

D-KEFS Verbal Fluency
The Delis-Kaplan Executive Function System (D-KEFS) (Delis, et al., 2001) was
designed to detect even the mildest forms of executive dysfunction (Delis, et al., 2004).
The D-KEFS Verbal Fluency Test requires the participant to say words that begin with a
specified letter, say words that belong to a designated semantic category, and alternate
between saying words from two different semantic categories. The internal consistency
for the verbal fluency test is reported to be marginal (.60-.69), however the test re-test
reliability is adequate (.70-.79). In terms of validity, it ranges from .44 to .83 when
comparing semantic category switching and letter fluency (Delis et al., 2004). This study
utilized various aspects of verbal fluency including phonemic fluency, semantic fluency,
category switching and switching accuracy. These aspects were averaged to create an
overall verbal fluency composite score.

Rey Osterrieth Complex Figure Test
The Rey-Osterrieth Complex Figure Test (ROCFT) was designed to assess visualspatial constructional ability and visual memory. Examinees are asked to reproduce a
complicated line drawing, first by copying and then from memory. It was developed by
Rey (1941) and then was elaborated by Osterrieth (1944). Internal consistency was
calculated by computing split-half and alpha coefficients (Berry et al., 1991; Fasteneau et
al., 1996). Both split-half and coefficient alpha reliabilities were greater than .60 for the
copy condition and .80 for recall conditions. Meyers and Meyers (1995) correlated
scores of normal individual’s performances on the ROCF and found the largest
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correlations to be between immediate recall and delayed recall (r= .88). Immediate recall
and delayed recall demonstrated low, but significant correlations with Recognition Total
Correct (r= .15).

The Structured Interview for Prodromal Syndromes (SIPS)
The SIPS is a structured diagnostic interview used to identify the three prodromal
syndromes. These syndromes are thought to be (1) frankly psychotic positive symptoms
that appeared too brief and too intermittent to constitute a fully psychotic syndrome, (2)
attenuated positive symptoms, and (3) functional decline in the presence of genetic risk
(Yung et al. 1996, 1998). The SIPS includes the SOPS, the Schizotypal Personality
Disorder Checklist (APA 1994), a family history questionnaire (Andreasen et al. 1977),
and a version of the Global Assessment of Functioning scale (GAF; Hall 1995). The
SIPS is used to operationally define the three prodromal syndromes using the Criteria of
Prodromal Syndromes (COPS) and psychosis onset by evaluating the Presence of
Psychotic Syndrome (POPS). Information from the COPS and the POPS are evaluated in
terms of the positive symptoms of the schizotypal personality disorder checklist and the
family history questionnaire in order to determine if a diagnosis of a prodromal syndrome
or the presence of psychosis should be given. This diagnostic interview addresses
positive, negative, disorganized, and general symptoms (see Appendix C). For the
purposes of this study, we will only be focusing on total positive and total negative
symptoms.

Research Site and Procedures
Participants between the ages of 10 and 25 with previously confirmed 22q11.2DS
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were recruited through distribution of fliers to research sites and genetic clinics as well as
word-of-mouth. Interested families contacted the research coordinator at UCLA and
underwent an initial phone screening to determine eligibility. On the day of the visit, the
child undergoes cognitive testing, magnetic resonance imaging (MRI), a blood draw, and
the Autism Diagnostic Observation Schedule (ADOS). Depending on the age and
cognitive ability, he or she is also asked to complete a short packet of questionnaires.
The parent completes the Autism Diagnostic Interview-Revised (ADI-R), the Diagnostic
Interview Schedule for Children (DISC), and a packet of questionnaires. Cognitive
testing was conducted by advanced graduate students in clinical psychology and took
place in a quiet room. The MRI was conducted at the Abrahamson-Lovelace Brain
Mapping Center and autism diagnostic measures were administered by trained staff at the
UCLA Autism Evaluation Clinic. All families received a summary report that included
the results of cognitive testing as well as diagnostic impressions.

Cognitive Testing
The testing battery included measures of visuospatial ability such as the Rey
Osterrieth Complex Figure Test (ROCFT) and the Children’s Memory Scale (CMS)
Faces and Dot Locations. The ROCFT is designed to assess visual-spatial constructional
ability and visual memory (Rey, 1941; Osterrieth, 1944). Examinees are asked to
reproduce a complicated line drawing, first by copying and then from memory. CMS
Faces and Dot Locations assess recall for spatial location and recognition of human faces
(Cohen, 1997). Social cognition was measured with the Animations task, Penn Emotion
Identification/Discrimination Tasks, and Awareness of Social Inference Task (TASIT).
The Animations task requires the examinee to observe shapes on a screen performing
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human-like actions and describe what the shapes are doing. The Penn Emotion
Identification/Discrimination Tasks is a computer-based test that includes 96 color
photographs of facial expression of evoked or felt emotions: happy, sad, angry, fearful,
disgusted, and non-emotional or neutral. Participants are asked to rate the emotional
valence of each expression (Kohler, Turner, Bilker, Brensinger et al. 2003). The TASIT
is an audiovisual tool designed for the clinical assessment of social perception. The task
assesses emotion recognition, the ability to interpret conversational remarks meant
literally (i.e., sincere remarks and lies) or non-literally (i.e., sarcasm) as well as the ability
to make judgments about the thoughts, intentions and feelings of speakers (McDonald,
Bornhofen, Shum, Long, et al., 2007). Memory was assessed with the California Verbal
Learning Test for children (CVLT-C). The CVLT-C requires the examinee to recall two
word lists over immediate and delayed memory trials (Delis et al., 1994). Speed of
processing was measured with the Brief Assessment of Cognition in Schizophrenia
Symbol Coding (BACS). The BASC is a timed task where the examinee is asked to use a
key to write numbers that correspond to nonsense symbols (Keefe et al., 2004).
Attention, psychomotor speed and mental flexibility was measured with the Trail-making
Test Part A & B. It requires the subject to connect by making pencil lines, encircled
numbers randomly arranged on a page in proper order (Part A) or for Part B encircled
numbers and letters in alternating order (Reitan, 1955). General cognitive
function/assessment of premorbid intelligence was assessed using the WASI Matrix
Reasoning & Vocabulary. Matrix reasoning requires the respondent to look at a picture
with a section missing and identify the missing part by pointing or by the number of one
of five choices and the vocabulary task requires the respondent to provide oral definitions
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to words (The Psychological Corporation, 1999). The University of Maryland Letternumber Span task was used to measure working memory. This task requires mental
reordering of orally presented lists with letters and numbers and repeating them back
(Holmen at al., 2010). Executive function was measured with the Delis-Kaplan
Executive Function System Verbal Fluency (D-KEFS). The D-KEFS Verbal Fluency
Test requires the participant to say words that begin with a specified letter, say words that
belong to a designated semantic category, and alternate between saying words from two
different semantic categories (Delis, et al., 2004). Attention was measured by Simple
Reaction Time, the Continuous Performance Test (CPT-II), and Time Reproduction.
Simple reaction time is a computerized task that requires the subject to press a button
whenever they see the target stimulus appear on the screen. The CPT-II is a computeradministered measure of sustained attention in which the respondent presses a response
button whenever they see consecutive matching numbers. Risk taking behavior was
assessed with the Balloon Analog Risk Task (BART). In the BART the participant is
presented with a balloon and offered the chance to win a prize by pumping the balloon up
by clicking a button. Each click causes the balloon to incrementally inflate and earn the
participant points to be added to a counter up until some threshold, at which point the
balloon is over inflated and explodes (Lejuez et al., 2002).

Interviews/Questionnaires
The Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al.
2001; Miller et al. 2002; Rosen et al. 2002) and Autism Diagnostic Observation Schedule
(ADOS) are conducted. The parent completes the Autism Diagnostic Interview-Revised
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(ADI-R), the Diagnostic Interview Schedule for Children (DISC), and a packet of
questionnaires.

Statistical Analyses
T-tests
In order to evaluate the hypothesis 22qDS patients will show the greatest
impairment relative to healthy controls on measures of psychomotor speed and mental
flexibility (Trail-making test part B), working memory (Letter-Number Sequencing), and
the D-KEFS verbal fluency composite, T-tests were run. T-tests were also run with
comparison measures outside of the executive domain namely, Vocabulary, Matrix
Reasoning, and the Rey Osterrieth Complex Figure test (copy portion). Effect sizes were
also calculated for all of these measures to assess the magnitude of the difference
between the patient and control groups.

Pearson’s Correlations
To determine the convergent and discriminant validity between and amongst the
executive measures, visuospatial ability, and total positive and total negative psychotic
symptoms and to determine which predictor variables (dependent variables) to include in
the regression analyses, Pearson’s correlations were calculated.

Regression
In order to evaluate the hypothesis executive deficits in working memory (LetterNumber Sequencing), and the D-KEFS verbal fluency composite will be significantly
predictive of total positive and total negative symptomatology above and beyond non25

verbal visuospatial deficits (copy portion of the Rey Osterrieth Complex Figure Test) in
22qDS patients, multiple regression analyses were conducted. For the regression analysis
predicting total positive symptoms, in order to control for age, age was entered into the
first block. Visuospatial ability was included in the second block and working memory
and the verbal fluency composite score were entered into the third block. For the
regression analysis predicting total negative symptoms, age was also controlled for.
Visuospatial ability was entered into the second block. Only working memory was
entered into the third block because the verbal fluency composite score was not
significantly correlated with total negative symptoms.

Power Analyses
A post hoc power analysis was conducted using the software package, G*Power
(Faul and Erdfelder, 1992) to determine the power for our t-tests. Our sample size of 48
for our patient group and sample size of 37 for our control group was utilized. The alpha
level used for this analysis was p < .05. The post hoc analysis revealed that with the
statistical power for our t-test we had a 98% chance to detect a large effect (i.e., Cohen’s
d of .80), a 73% chance to detect a medium effect (i.e., Cohen’s d of .50) and a 23%
chance to detect a small effect (i.e., Cohen’s d of .20) given our sample size.
A post hoc power analysis was also conducted for our regression analyses. The
post hoc analysis revealed that the statistical power for our regressions produced a 92%
chance to detect a large effect (i.e., f2= .35), 56% chance to detect a medium effect (i.e.,
f2= .15) and an 11% chance (i.e., f2= .02) to detect a small effect given our sample size.
Thus, for both the t-test and regressions there was more than sufficient power at the large
effect size but less than adequate power at the small effect size.
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CHAPTER FIVE
RESULTS

Independent Samples T-tests
T-tests were run to analyze significant differences between 22qDS patients and
controls on executive measures and other comparison tests including Vocabulary, Matrix
Reasoning, and the Rey Osterrieth Complex Figure test (copy portion). Effect sizes were
also calculated and these results are depicted in Figure 1. 22qDS patients (N= 48, mean
age: 15.23) showed impairment relative to healthy controls (N= 37, mean age: 14.97) on
all measures of cognition. See table 1 for subject demographics and table 2 for results of
t-tests.

Figure 1. Group Differences.
Note. Cognitive measure effect sizes. ROCFT= Rey Osterrieth Complex Figure test
copy portion; Matrix= Matrix Reasoning; TMT-B= Trail-making test part B; LNS=
Letter Number-Sequencing; DKEFS Comp= Delis-Kaplan Executive Function System
composite score. Composite score calculated as the average of phonemic fluency,
semantic fluency, category switching and switching accuracy.
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Table 1
Subject Demographics
22qDS (N=48)

Controls (N=37)

15.23

14.97

26 (54.2%)

17 (45.9%)

42 (87.5%)

22 (59.5%)

Black/African American

1 (2.1%)

5 (13.5)

Asian

0 (0.0%)

3 (8.1%)

Multiple

5 (10.4%)

7 (18.9%)

Age
Gender (N, % female)
N, % race
Caucasian

Table 2
Mean Scores of Cognitive Measures for 22qDS and Controls
Groups
22qDS

Controls

t

df

Working Memory

10.3542
(5.12603)

14.7568
(4.03736)

-6.773*

83

Verbal Fluency
Composite

61.9323
(17.43893)

89.9054
(23.04271)

-6.373*

83

Psychomotor
Speed/Mental
Flexibility

113.5585
(65.38445)

63.8951
(27.73643)

4.657*

81

Visuospatial Ability

22.5114
(6.66254)

30.2222
(5.76497)

-5.467*

78

Vocabulary

36.5625
(10.58282)

55.1081
(13.82386)

-6.773*

83

Matrix Reasoning

15.333
24.8378
-6.295*
(7.60552)
(6.30482)
Note. *p< .01. Standard Deviations appear in parentheses below means.

28

83

Pearson’s Correlations
To determine the convergent and discriminant validity between and amongst the
executive measures, visuospatial ability, and total positive and total negative psychotic
symptoms and to determine which predictor variables to include in the regression
analyses, Pearson’s correlations were calculated. Results are listed in Table 3. The
executive measures that significantly correlated (p < .05) with total positive and total
negative psychiatric symptoms were included in the regression analyses. Working
memory (Letter-Number Sequencing) and the Verbal Fluency Composite Score (Average
of D-KEFS verbal letter fluency, category fluency, category switching, and switching
accuracy) were significantly correlated with total positive symptoms, p < .05. Only
working memory was significantly correlated with total negative symptoms.
Psychomotor speed and mental flexibility (Trail-making test part B) was not significantly
correlated with total positive and total negative symptoms. Therefore, it was not included
in the regression analyses.
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Table 3
Summary of Correlational Analyses for Executive Measures and SIPS Symptoms
Working
Memory

Verbal
Fluency

Psychomotor
speed

Visuospatial
Ability

Positive
Total

Negative
Total

Working
Memory

_

.545**

-.559**

.334*

-.431**

-.369*

Verbal
Fluency

.545**

_

-.369*

.587**

-.481**

-.274

Psychomotor
speed

-.559**

-.369

_

-.207

.007

.177

Visuospatial
Ability

.334*

.587**

-.207

_

-.203

-.295

Positive
Total

-.431**

-.481**

.007

-.203

_

.528**

Negative
Total

-.369*

-.274

.177

-.295

.528**

-

Note. * p<.05; ** p<.01. Verbal Fluency= Verbal Fluency Composite Score,
Psychomotor speed= Psychomotor speed/mental flexibility.

Regression
To address the hypothesis that deficits on D-KEFS verbal fluency composite, and
working memory (Letter-Number Sequencing) will be significant predictors of SIPS total
positive and total negative symptoms, and will be significantly predictive of positive and
negative symptomatology above and beyond non-verbal visuospatial deficits (copy
portion of the Rey Osterrieth Complex Figure Test) in 22qDS patients, multiple
regression analyses were conducted. Overall, this analysis was used to determine if the
addition of executive measures would improve prediction of psychotic symptoms beyond
that afforded by visuospatial ability.
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Results revealed that the optimal linear combination of age, the copy portion of
the Rey-Osterrieth Complex Figure Test, Letter-Number Sequencing, and the D-KEFS
verbal fluency composite score accounted for 32% of the variance in total positive
psychiatric symptoms (R2 = .32). On average for every one-point increase in the D-KEFS
verbal fluency composite score, total positive symptoms decreased by .224 points (b = .224, 95% CI [-.407, -.041], p < .05). The copy portion of the Rey Osterrieth Complex
Figure test (b = .144, 95% CI [-.268, .555], p > .05 and Letter-Number Sequencing (b = .358, 95% CI [-1.088, .371], p > .05; were not significant individual predictors.
Therefore, the model was driven by the D-KEFS verbal fluency composite score. See
figure 2 and table 4.

Figure 2. Variance Explained by Regression with Rey Osterrieth Complex Figure Test
Copy Portion and Executive Measures Predicting Total Positive Symptoms
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Table 4
Results of Hierarchical Regression Analysis with Visuospatial Ability and Executive
Measures Predicting Total Positive Symptoms
b

β

t

Sig.

95% CI (b)

Step 1

ΔR2
.000

(Constant)

7.255

Age

.002

.001

1.519

.140

[-2.513, 17.022]

.008

.994

[-.602, .606]

Step 2

.045

(Constant)

10.857

1.906

.067

[-.811, 22.525]

Age

.098

.062

.321

.750

[-.527, .723]

Visuospatial
ability

-.219

-.220

-1.146

.261

[-.609, .179]

Step 3

.279*

(Constant)

14.583

2.846

.009

[4.051, 25.116]

Age

.424

.267

1.486

.149

[-.162, 1.010]

Visuospatial
ability

.144

.145

.718

.479

[-.268, .555]

Working
memory

-.358

-.202

-1.010

.322

[-1.088, .371]

Verbal Fluency
Composite

-.224

-.569

-2.511

.019

[-.407, -.041]

There were no linear combinations that resulted in significance regarding total
negative symptoms. Additionally, the copy portion of the Rey-Osterrieth Complex
Figure Test (b = .226, 95% CI [-.663, .211], p < .05), and Letter Number Sequencing (b =
-.657, 95% CI [-1.439, .125], p < .05) were not found to be significant individual
predictors of negative symptoms. See figure 3 and table 5.
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Figure 3. Variance Explained by Regression with Rey Osterrieth Complex Figure Test
Copy Portion and Executive Measures Predicting Total Negative Symptoms

Table 5
Results of Hierarchical Regression Analysis with Visuospatial Ability and Executive
Measures Predicting Total Negative Symptoms
b

β

t

Sig.

95% CI (b)

Step 1

.012

(Constant)

6.242

Age

.193

.111

1.202

.239

[-4.375, 16.860]

.601

.553

[-.464, .849]

Step 2
(Constant)

.114
12.540

2.105

.044

[.338, 24.742]

Age

.360

.207

1.128

.269

[-.294, 1.014]

Visuospatial
Ability

-.382

-.352

-1.916

.066

[-.791, .026]

Step 3
(Constant)

ΔR2

.087
13.290

2.302

.029

[1.443, 25.138]

Age

.460

.264

1.464

.155

[-.185, 1.104]

Visuospatial
Ability

-.226

-.208

-1.060

.299

[-.663, .211]

Working
Memory

-.657

-.339

-1.724

.096

[-1.439, .125]
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Discussion
We hypothesized that 22qDS patients will show the greatest impairment relative
to healthy controls on measures of executive functioning and non-executive comparison
measures. This investigation partially confirmed our hypothesis as 22qDS patients
showed impairment relative to healthy controls on psychomotor speed and mental
flexibility (Trail-making Test Part B), working memory (Letter-Number Sequencing),
verbal fluency (Composite score: D-KEFS phonemic fluency, semantic fluency, category
switching and switching accuracy), non-verbal abstract problem solving (Matrix
Reasoning), Vocabulary, and visuospatial ability (Rey Osterrieth Complex Figure test
copy portion). However, we also calculated effect sizes to assess the magnitude of the
difference between the two groups on cognitive measures. As depicted in figure 1, large
effect sizes were demonstrated for Vocabulary (Cohen’s d= 1.51), Matrix Reasoning
(Cohen’s d= 1.36), and the Rey Osterrieth Complex Figure test copy portion (Cohen’s d=
1.24). Although the 22qDS group appears to show deficits in multiple domains, we
believe executive function deficits are more relevant to psychotic symptom development.
This makes sense given that the Rey Osterrieth Complex Figure test copy portion was not
significantly correlated with positive or negative symptoms while the executive measures
were.
Our second hypothesis purported that deficits on the verbal fluency composite,
psychomotor speed and mental flexibility (Trail-making Test Part B), and working
memory (Letter- Number Sequencing) will be significant predictors of total positive and
total negative symptoms, above and beyond non-verbal visuospatial deficits (copy
portion of the Rey Osterrieth Complex Figure Test) in 22qDS patients. This hypothesis
was partially supported. For the regression analysis predicting total positive symptoms,
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executive measures accounted for 32% of the variance. The D-KEFS verbal fluency
composite scores drove this finding; executive measures did add meaningfully to the
prediction of total positive symptoms. This finding is inline with our hypothesis. In the
regression analysis predicting total negative psychological symptoms, however, the
model was not significant and there were no significant individual predictors p> .05.
This lack of significance may be due to the limited power. We had an 11% chance to
detect a small effect with our regressions given our sample size.
Overall, these results can be interpreted to mean executive deficits are predictive
of total positive symptoms above and beyond non-verbal visuospatial abilities. This
information is very useful because cognitive deficits within the executive domain are a
prominent impairment also seen in schizophrenia. Being that cognitive deficits are
relatively stable across clinical state changes and present before the onset of
clinical/psychotic symptoms (Finklestein et al., 1997; Gold 2004; Crow, Done, and
Sacker, 1995), it is important to assess executive function in 22qDS, considering its
relationship with schizophrenia. The consistency and prominence of executive deficits in
schizophrenia may be associated with conversion to this disorder in 22qDS. Assessing
whether these deficits are associated with positive and negative psychological symptoms
in 22qDS is a novel and valuable pursuit.
Along with Green (2006) we are in favor of evaluating cognitive deficits as they
relate to schizophrenia. Green suggests evaluating and treating cognitive deficits in
patients that are currently suffering from schizophrenia. He argues that cognitive deficits
can serve as endophenotypes for the genetic basis of schizophrenia because they show
characteristics that are associated with genetic vulnerability to the illness (Finkelstein,
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Cannon, Gur et al., 1997). We also believe that cognitive deficits, specifically executive
deficits can serve as an endophenotype for the genetic basis of schizophrenia in 22qDS.
Evaluating persons with 22qDS in terms of executive function over various time points
will provide a different means to study and understand schizophrenia. This information
may lead to identifying executive dysfunction in 22qDS as a potential risk factor for the
later development of psychoses/schizophrenia, which may aid in early detection. Data
has suggested that early intervention with medication in first-break patients with
schizophrenia increases the likelihood of an improved long-term course (Wyatt, 1991).
Using executive function as an endophenotypic marker for positive and negative
psychological symptoms is a novel concept, can ultimately lead to early detection and
earlier treatment, and some relief of the burden schizophrenia poses to the individual, the
caregiver, and society.

Limitations
The limitation of our study was the issue of power. A post hoc power analysis
revealed that given our sample size of 48 in the 22qDS group we had an 11% chance to
detect a small effect with our regressions. We did not have any significant findings for
our regression analysis with visuospatial ability and executive function predicting total
negative symptoms. Perhaps with more power to detect a small effect significant
findings may have resulted with this regression.

Future Directions
Our results suggest that executive function may be an important domain for
providing information about the development of psychosis. This study utilized a cross
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sectional design. Future directions include employing a longitudinal design in order to
detect progression of positive and negative psychotic symptoms over various time points.
Furthermore, this research leads to questions regarding the neurobiological basis of
executive function deficits in 22qDS. Investigations of these questions are already
underway. Future directions also include replicating this study with a larger sample to
insure greater power for detecting effects. Replication of this study with a larger sample
size may also lead to the creation of a questionnaire or battery of tests specifically used in
the detection of increased psychiatric symptoms coupled with a decrease in executive
function for patients with 22qDS.
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APPENDIX A
THE DEL22Q11.2 REGION ON CHROMOSOME 22
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APPENDIX B
FACIAL DYSMORPHIA

Figure 2. Facial dysmorphia, characteristic facial feature in chromosome 22q11.2
deletion syndrome. A slightly bulbous nose tip and hooded eyes are the primary features.
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APPENDIX C
ORGANIZATION OF THE SIPS AND THE SOPS AND LISTING OF
ASSOCIATED ACRONYMS
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